Minimal impact of sofosbuvir and ribavirin on health related quality of life in Chronic Hepatitis C (CH-C)

Journal of Hepatology

Volumn 60, Issue 4, 2014, Pages 741-747

  Younossi, Zobair M ^a,b   Stepanova, Maria ^a,b   Henry, Linda ^b   Gane, Edward ^c   Jacobson, Ira M ^d   Lawitz, Eric ^e   Nelson, David ^f   Nader, Fatema ^a   Hunt, Sharon ^a,b  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b Betty and Guy Beatty Center for Integrated Research   (United States)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

Clinical trials; Hepatitis C; Quality of life

Indexed keywords

PEGINTERFERON; PLACEBO; RIBAVIRIN; SOFOSBUVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN; URIDINE PHOSPHATE;

ANEMIA; ANTIVIRAL THERAPY; ARTICLE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; EMOTION; FATIGUE; FOLLOW UP; HEALTH; HEPATITIS C; HUMAN; INSOMNIA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MENTAL HEALTH; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SOCIAL INTERACTION; TREATMENT DURATION; ADULT; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HEPATITIS C, CHRONIC; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MENTAL HEALTH; MIDDLE AGED; POLYETHYLENE GLYCOLS; QUALITY OF LIFE; RECOMBINANT PROTEINS; RIBAVIRIN; URIDINE MONOPHOSPHATE;

EID: 84896404567     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.12.006     Document Type: Article

References (21)

1. G.R. Foster, R.D. Goldin, and H.C. Thomas Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis Hepatology 27 1998 209 212
2. J.E. Ware Jr., M.S. Bayliss, and M. Mannocchia et al. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group Hepatology 30 1999 550 555
3. Z. Younossi, J. Kallman, and J. Kincaid The effects of HCV infection and management on health-related quality of life Hepatology 45 2007 806 816
4. G.L. Davis, L.A. Balert, and E.R. Schiff et al. Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile Clin Ther 16 1994 334 343
5. A.J. Rodger, D. Jolley, and S.C. Thompson et al. The impact of diagnosis of hepatitis C virus on quality of life Hepatology 30 1999 1299 1301
6. D. Bernstein, L. Kleinman, and C.M. Barker et al. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients Hepatology 35 2002 704 708
7. H.B. El-Serag Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 2012 1264 1273.e1 10.1053/j.gastro.2011.12.061
8. Pyenson B, Fitch K, Iwasaki K. Consequences of hepatitis C virus (HCV): costs of a baby boomer epidemic of liver disease. Available from: http://publications.milliman.com/research/health-rr/pdfs/consequences-hepatitis- c-virus-RR05-18-09.pdf [Last accessed on 17 July 2013].
9. T. Hassanein, G. Cooksley, and M. Sulkowski et al. The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C J Hepatol 40 2004 675 681
10. J. Rasenack, S. Zeuzem, and S.V. Feinman et al. Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C Pharmacoeconomics 21 2003 341 349
11. Z.M. Younossi, M. Stepanova, M. Afendy, B.P. Lam, and A. Mishra Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C J Viral Hepat 20 2013 550 555 10.1111/jvh.12080 [Epub 2013 Mar 25]
12. E. Lawitz, A. Mangia, D. Wyles, M. Rodriguez-Torres, T. Hassanein, and S.C. Gordon et al. Sofosbuvir for previously untreated chronic hepatitis C infection N Engl J Med 368 2013 1878 1887
13. I.M. Jacobson, S.C. Gordon, K.V. Kowdley, E.M. Yoshida, M. Rodriguez-Torres, and M.S. Sulkowski et al. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options N Engl J Med 368 2013 1867 1877
14. R.D. Hays, and L.S. Morales The RAND-36 measure of health-related quality of life Ann Med 33 2001 350 357
15. G.L. Davis, and W.L. Roberts The healthcare burden imposed by liver disease in aging Baby Boomers Curr Gastroenterol Rep 12 2010 1 6 10.1007/s11894-009-0087-2
16. B.M. Spiegel, Z.M. Younossi, R.D. Hays, D. Revicki, S. Robbins, and F. Kanwal Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment Hepatology 41 2005 790 800
17. J. Kallman, M.M. O'Neil, B. Larive, N. Boparai, L. Calabrese, and Z.M. Younossi Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection Dig Dis Sci 52 2007 2531 2539 [Epub 2007 Apr 4]
18. M.M. Manos, C.K. Ho, R.C. Murphy, and V.A. Shvachko Physical, social, and psychological consequences of treatment for hepatitis C: a community-based evaluation of patient-reported outcomes Patient 6 2013 23 34 10.1007/s40271-013-0005-4
19. M. Tavakkoli, S.J. Ferrando, J. Rabkin, K. Marks, and A.H. Talal Depression and Fatigue in chronic hepatitis C patients with and without HIV co-infection Psychosomatics 2013 10.1016/j.psym.2013.02.009 pii: S0033-3182(13)00047-9 [Epub ahead of print]
20. Younossi ZM, Stepanova M, Henry L, Gane E, Jacobson IM, Lawitz E, et al. Sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2013. pii: S1542-3565(13)01838-7. http://dx.doi.org/10.1016/j.cgh.2013.11.032 [Epub ahead of print].
21. M. Schaefer, L. Capuron, A. Friebe, C. Diez-Quevedo, G. Robaeys, and S. Neri et al. Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement J Hepatol 57 2012 1379 1390 10.1016/j.jhep.2012.07.037 [Epub 2012 Aug 7]